home / stock / argnf / argnf short
Short Information | Argen X NV (OTCMKTS:ARGNF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 18,796 |
Total Actual Volume | 18,907 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 13 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 940 |
Average Short Percentage | 69.02% |
Is there a ARGNF Short Squeeze or Breakout about to happen?
See the ARGNF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-18-2024 | $0 | $383.74 | $0 | $0 | 136 | 136 | 100% |
12-22-2023 | $371 | $371 | $371 | $371 | 19 | 19 | 100% |
12-20-2023 | $428.6 | $341 | $428.6 | $341 | 3 | 1 | 33.33% |
11-10-2023 | $505 | $505 | $505 | $505 | 5 | 5 | 100% |
06-10-2022 | $335 | $335 | $335 | $335 | 30 | 30 | 100% |
05-09-2022 | $293.5 | $290 | $293.5 | $290 | 206 | 97 | 47.09% |
05-06-2022 | $308.15 | $312.75 | $312.75 | $308.15 | 42 | 42 | 100% |
03-19-2021 | $309 | $309 | $309 | $309 | 1 | 1 | 100% |
07-08-2020 | $248.6 | $248.6 | $248.6 | $248.6 | 129 | 129 | 100% |
01-13-2020 | $161.96 | $161.96 | $161.96 | $161.96 | 13,300 | 13,300 | 100% |
12-02-2019 | $N/A | $128.24 | $N/A | $N/A | 4 | 4 | 100% |
11-12-2019 | $128.24 | $128.24 | $128.24 | $128.24 | 5,000 | 5,000 | 100% |
05-03-2018 | $N/A | $85.00 | $N/A | $N/A | 25 | 25 | 100% |
04-10-2018 | $N/A | $85.00 | $N/A | $N/A | 4 | 4 | 100% |
04-05-2018 | $N/A | $85.00 | $N/A | $N/A | 3 | 3 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Argen X NV Company Name:
ARGNF Stock Symbol:
OTCMKTS Market:
ADHERE data show VYVGART ® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART ® treatment April 16, 2024...
RHO study supports proof-of-concept in primary Sjogren’s disease Decision informed by favorable safety profile and consistency across efficacy and biomarker measures March 27, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ...
March 26, 2024 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Annual General Meeting of shareholders will be held at 1...